Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-22
1996-10-01
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514340, 544335, 5462714, 548232, 548229, C07D26338, A61K 3142
Patent
active
055611486
ABSTRACT:
Novel oxazolidinone derivatives of the formula I ##STR1## in which R.sup.1 is a phenyl radical which is unsubstituted or is monosubstituted by CN, H.sub.2 N--CH.sub.2 --, A.sub.2 N--CH.sub.2 --, H.sub.2 N--C(.dbd.NH)--, H.sub.2 N--C(.dbd.NH)--NH--, H.sub.2 N--C(.dbd.NH)--NH--CH.sub.2 --, HO--NH--C(.dbd.NH)-- or HO--NH--C(.dbd.NH)--NH--,
REFERENCES:
patent: 4374990 (1983-02-01), Weber et al.
patent: 4602093 (1986-07-01), Baldwin et al.
patent: 4970217 (1990-11-01), Prucher et al.
patent: 5053393 (1991-10-01), Tjoeng et al.
patent: 5232931 (1993-08-01), Pr ucher et al.
"Low Molecular Weight, Non-Peptide Fibrinogen Receptor Antagonists", Alig et al., J. Med. Chem. , vol. 35, 1992, pp. 4393-4407.
"Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based upon the Arg-Gly-Asp-Phe Sequence of Fibrinogen. A Proposal on the Nature of the Binding Interaction between the Arg-guanidine of RGDX Mimetics and the Platelet GP IIb-IIIa Receptor". Zablocki et al., J. Med. Chem., vol. 36, 1993, pp. 1811-1819.
Y. Iwakura et al., Bulletin of the Chemical Society of Japan, "2-Oxazolidones from Glycidyl Ether Reactions with acid Amides", vol. 39, pp. 2490-2494 (1966).
Iwakura et al. Chem Abstr vol. 64 Entry 8163a (1961).
Iwakura et al. Chem Abstr vol. 67 Entry 108577 (1966).
Burger, "Medicinal Chemistry" 2d. Ed. Inter-Science, New York, 1960 p. 42.
Bernotat-Danielowski Sabine
Gante Joachim
Juraszyk Horst
Melzer Guido
Raddatz Peter
Daus Donald G.
Merck Patent Gesellschaft mit beshrankter Haftung
LandOfFree
Adhesion receptor antagonists III does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adhesion receptor antagonists III, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion receptor antagonists III will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1502184